Natick, MA, United States of America

Bryan Johnson

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations by Inventor Bryan Johnson

Introduction

Bryan Johnson is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies for therapeutic applications. With a total of four patents to his name, Johnson's work focuses on anti-neoplastic agents that target specific receptors involved in cancer progression.

Latest Patents

Johnson's latest patents include the development of monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies. These antibodies are designed to bind specifically to human IGF-1R and human ErbB3, which are critical in cancer signaling pathways. The exemplary antibodies provided in his patents inhibit signal transduction through either or both of these receptors. Additionally, the patents describe polyvalent proteins that comprise at least one anti-IGF-1R binding site and at least one anti-ErbB3 binding site. In certain embodiments, these binding sites may be linked through an immunoglobulin constant region, enhancing their therapeutic potential.

Career Highlights

Bryan Johnson is currently associated with Merrimack Pharmaceuticals, Inc., where he continues to advance his research in antibody development. His work has been instrumental in creating innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes through scientific advancements.

Collaborations

Johnson collaborates with talented individuals in his field, including Jason Baum and Alexey Alexandrovich Lugovskoy. These collaborations enhance the research and development efforts at Merrimack Pharmaceuticals, fostering an environment of innovation and discovery.

Conclusion

Bryan Johnson's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor in the development of targeted cancer therapies. His work continues to pave the way for advancements in medical science, ultimately benefiting patients in need of effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…